Pancreatic Cancer Research

EditorialTransl Cancer Res2020

Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment.

Journal
Transl Cancer Res
Published
1 April 2020
Citations
1
Type
Editorial
License
cc by-nc-nd

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try